Clinical Trial Update: A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast [Phase 3]

View source ↗

Summary

A Phase 3 follow-up trial is planned to assess long-term treatment with Nerandomilast in people with idiopathic pulmonary fibrosis or progressive pulmonary fibr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Progressive Pulmonary Fibrosis

Drugs mentioned

• Nerandomilast

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis | Phase 3 | Status: RECRUITING